SIHealthcare · Medical Devices

SI Stock Forecast: Shoulder Innovations, Inc. Price Predictions for 2026-2027

Last close, 30 Oct 2026
$19
−4.92% on the day

The 4 Wall Street analysts covering Shoulder Innovations, Inc. hold a median 12-month price target of $27 — +36.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 35 of 100 as at 31 Oct 2026 — in the lower half. The Street sees upside; the factor read is a caution. That gap is the story on this page.

Market cap
$400.8M
Ticker Nerd rank
35/ 100
Median analyst target
$27
Analysts covering
4
Revenue$17.2M+56.0% y/y
Operating income−$10.0M
Net income−$10.2M
Free cash flow−$9.5M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−1.1%
1M
+2.8%
YTD
+35.9%
1Y
+63.3%
From 52W high
−19.9%
From 52W low
+76.5%
$11
$24
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

SI stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Shoulder Innovations, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 31 Oct 2026
35/ 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Momentum
69
Revisions
68
Issuance
56
Size
55
Growth
51
Volatility
28
Value
22
Quality
20
Accruals
18

Momentum (69): The shares have been drifting up relative to others.

Accruals (18): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

SI stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on SI, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$10$15$20$25$30Jan 26Apr 26Jul 26Oct 26SIHigh $28Median $27Low $25

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says4 analysts
4 Buy0 Hold0 Sell
Low $25Median $27High $28

The green dot is the last close — the median target sits +36.4% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 5 moved their price target up and 0 moved it down.

DateFirmActionRatingTarget
12 Oct 2026BTIGMaintainsBuy$26 → $27
10 Aug 2026UBSMaintainsBuy—
10 Aug 2026UBSMaintainsBuy$27 → $28
7 Aug 2026BTIGMaintainsBuy$24 → $26
7 Aug 2026BTIGMaintainsBuy—
7 Aug 2026Piper SandlerReiteratesOverweight—
7 Aug 2026Piper SandlerReiteratesOverweight$19 → $25
28 July 2026UBSInitiatesBuy—
28 July 2026UBSInitiatesBuy$27
8 May 2026Piper SandlerReiteratesOverweight—
8 May 2026Piper SandlerReiteratesOverweight$18 → $19
11 Mar 2026BTIGMaintainsBuy—
2 Dec 2025Morgan StanleyMaintainsOverweight—
12 Nov 2025Piper SandlerReiteratesOverweight—
9 Sept 2025BTIGReiteratesBuy—
26 Aug 2025Morgan StanleyInitiatesOverweight—
25 Aug 2025Goldman SachsInitiatesBuy—
25 Aug 2025JefferiesInitiatesBuy—
25 Aug 2025Piper SandlerInitiatesOverweight—
6 Mar 2023WedbushDowngradeUnderperform$4.00

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

SI appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track, part by part, and one part in full with each verdict.

Free. Unsubscribe any time.

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and serversIn full

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

SI vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 30 Oct 2026, Shoulder Innovations, Inc. returned +63.3% against +12.4% for the S&P 500, dividends included.

SI vs S&P 500, last 12 monthsTotal return, rebased to 100
80100120140160180200Jan 26Apr 26Jul 26Oct 26SIS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

SI analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
Analysts raising
0
Analysts cutting
2
Fundamentals

Shoulder Innovations, Inc. (SI) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
23.6×

Cheaper than 32% of US stocks

Price / sales
8.5×

Cheaper than 15% of US stocks

Price / book
3.2×

Cheaper than 29% of US stocks

EV / EBITDA
−16.8×

Cheaper than 89% of US stocks

Growth & margins
Revenue growth (YoY)
2.8%

Higher than 34% of US stocks

Earnings growth (YoY)
56.0%

Higher than 76% of US stocks

Gross margin
78.3%

Higher than 90% of US stocks

Operating margin
−85.1%

Higher than 15% of US stocks

Net margin
76.5%

Higher than 98% of US stocks

Returns & dividend
Return on equity
−28.7%

Higher than 28% of US stocks

Return on assets
−23.8%

Higher than 17% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Shoulder Innovations, Inc. (SI) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Shoulder Innovations, Inc. has a market value of $400.8M and an enterprise value of $389.0M.

  • Revenue in the twelve months to 30 June 2026: $60.1M. The latest quarter grew 2.8% year on year.

  • Net income over the same four quarters: −$35.0M, a −58.3% net margin.

  • Diluted earnings per share, trailing twelve months: $−1.92.

  • Free cash flow in the twelve months to 30 June 2026: −$47.1M.

  • Shares outstanding: 20.8M.

  • Trailing P/E: 23.6×; forward P/E: −12.1× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Shoulder Innovations, Inc. employs 56 people — $1.1M of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 31 Oct 2026

Data provided by Twelve Data

Peers

SI vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
SIShoulder Innovations, Inc.$400.8M35
NPCENeuroPace, Inc.$414.1M91
VMDViemed Healthcare, Inc.$367.6M96
CVCapsoVision, Inc.$363.4M21
CERSCerus Corp.$438.0M94
OFIXOrthofix Medical, Inc.$359.2M68
MOBIMobia Medical, Inc.$350.0M3

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Shoulder Innovations, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest SI news & analysis

COPE Health Solutions Named Finalist in CMS QualTech for Super Intelligence (SI) Solution to Expand Medicare Annual Wellness Visits

Business Wire · 29 Oct 2026neutral

COPE Health Solutions was selected as a finalist for CMS’s QualTech event with its Super Intelligence solution to expand Medicare Annual Wellness Visits. CMS selected eight finalists from more than 300 submissions across four opportunity areas.

Why it matters — The item concerns a solution branded SI, but the excerpt does not establish a connection to Shoulder Innovations, Inc.

Shoulder Innovations to Participate in Upcoming Investor Conferences

PRNewsWire · 27 Oct 2026neutral

Shoulder Innovations announced that management will participate in the UBS Global Healthcare Conference on November 10 and the Jefferies Global Healthcare Conference on November 17. Live and archived webcasts of both events will be available on the company’s Investor Relations website.

Why it matters — The conferences provide SI watchers an opportunity to follow management’s presentations and fireside chats through the available webcasts.

BlockchAIn Digital Infrastructure Unveils $1B+ Nebius Data Center Lease Strategy

MarketBeat · 24 Oct 2026neutral

BlockchAIn Digital Infrastructure outlined a data-center development strategy focused on smaller, power-secured facilities, long-term tenant contracts and project-level financing. CFO Jolienne Halisky presented the strategy.

Why it matters — The item concerns another company’s data-center strategy and does not describe a direct development or business update for Shoulder Innovations.

BlockchAIn Digital Infrastructure Says Nebius Prepayment Funds $800M Data Center Build

MarketBeat · 8 Oct 2026neutral

BlockchAIn Digital Infrastructure said it plans to develop a 50-megawatt data center under a newly executed contract with Nebius. Management expects customer prepayments to cover the equity contribution the company must provide.

Why it matters — The item concerns another company's data center financing and has no stated direct connection to Shoulder Innovations.

FAQ

Frequently asked questions about SI stock

What is the SI stock price forecast for 2026-2027?

The 4 Wall Street analysts covering Shoulder Innovations, Inc. have a median 12-month price target of $27, with estimates ranging from $25 to $28. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is SI stock a buy right now?

Of the 4 analysts covering Shoulder Innovations, Inc., 4 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Shoulder Innovations, Inc. 35 out of 100 across roughly 4,600 US stocks as at 31 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank SI?

As at 31 Oct 2026, Shoulder Innovations, Inc. ranks 35 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (69 of 100).

Will SI stock go up?

No one can know that. What the data says: the median 12-month target from 4 analysts implies +36.4% from the last close, and Ticker Nerd's factor model ranks Shoulder Innovations, Inc. 35 out of 100 as at 31 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the SI stock forecast for 2030?

No analyst covering Shoulder Innovations, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for SI are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $25 to $28 over the next 12 months.

How has SI stock performed over the past year?

Shoulder Innovations, Inc. returned +63.3% over the 12 months to 30 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Shoulder Innovations, Inc. do?

Shoulder Innovations, Inc. is a commercial-stage medical technology company focused on shoulder arthroplasty solutions.

What is the latest news on SI?

The most recent item we track (Business Wire, 29 Oct 2026): "COPE Health Solutions Named Finalist in CMS QualTech for Super Intelligence (SI) Solution to Expand Medicare Annual Wellness Visits". COPE Health Solutions was selected as a finalist for CMS’s QualTech event with its Super Intelligence solution to expand Medicare Annual Wellness Visits. CMS selected eight finalists from more than 300 submissions across four opportunity areas.

Company

About Shoulder Innovations, Inc.

Shoulder Innovations, Inc. is a commercial-stage medical technology company focused on shoulder arthroplasty solutions. Shoulder Innovations designs, develops, manufactures, and distributes implant systems and related surgical tools used in shoulder replacement procedures. Its product portfolio includes advanced total and reverse shoulder arthroplasty systems, tray components, planning software, and enabling instruments that support preoperative planning, implant placement, and procedural efficiency. The company’s InSet Glenoid technology is central to its platform, supporting fixation and stability in shoulder implants while addressing clinical challenges in shoulder reconstruction. Shoulder Innovations serves hospitals, ambulatory surgery centers, surgeons, and orthopedic care teams that rely on specialized devices for shoulder surgery. Headquartered in Grand Rapids, Michigan, Shoulder Innovations focuses exclusively on the shoulder surgical care market, making it a specialized participant in the broader orthopedic medical device industry.

CEO Mr. Robert Ball · 56 employees · United States · https://www.shoulderinnovations.com